Article Information
History
- January 7, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Anning Bian1,†,
- Xiaoxue Ye1,†,
- Jing Wang1,†,
- Ming Zeng1,
- Jiayin Liu2,
- Kang Liu1,
- Song Ning2,
- Yugui Cui2,
- Shaowen Tang3,
- Xueqiang Xu1,
- Yanggang Yuan1,
- Zhonglan Su4,
- Yan Lu4,
- Jing Zhou2,
- Xiang Ma2,
- Guang Yang1,
- Yaoyu Huang1,
- Xiaolin Lv1,
- Ling Wang1,
- Jing Zhao5,
- Xiuqin Wang6,
- Ningxia Liang7,
- Changying Xing1,*,
- Lianju Qin2,* and
- Ningning Wang1,*
- 1Department of Nephrology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, No.300, Guangzhou Road, Nanjing 210029, People’s Republic of China
- 2State Key Laboratory of Reproductive Medicine, Center of Clinical Reproductive Medicine, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, No.368, Jiangdong North Road, Nanjing 210029, People’s Republic of China
- 3Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, No.101, Longmian Avenue, Jiangning District, Nanjing 211166, People’s Republic of China
- 4Department of Dermatology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, No.300, Guangzhou Road, Nanjing 210029, People’s Republic of China
- 5Department of Outpatient Treatment Clinic, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, No.300, Guangzhou Road, Nanjing 210029, People’s Republic of China
- 6Department of International Cooperation, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, No.300, Guangzhou Road, Nanjing 210029, People’s Republic of China
- 7Academy of Clinical and Translational Research, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, No.300, Guangzhou Road, Nanjing 210029, People’s Republic of China
- ↵*Correspondence to: Ningning Wang, E-mail: wangnn{at}njmu.edu.cn; Lianju Qin, E-mail: ljqin{at}njmu.edu.cn; Changying Xing, E-mail: cyxing62{at}126.com
↵† these authors contributed equally to this work
Posted January 07, 2023.
Therapeutic effects of human amnion-derived mesenchymal stem cells on hypercoagulability in a uremic calciphylaxis patient
